JPRN-UMIN000009392招募中2 期
An Open-Label, Dose Escalation, Proof-of-Concept Clinical Trial of Chaperone therapy of Neuronopathic Gaucher Disease with Ambroxol - Chaperone therapy of Neuronopathic Gaucher Disease with Ambroxol
Tottori University, Faculty of Medicine, Institute of Neurological Science0 个研究点目标入组 5 人开始时间: 2012年11月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with critical illness 2) Pregnant or lactating woman 3) Within 3 months from other clinical trial 4) Patients who are not appropriate to participate to the trial.
研究者
相似试验
已完成
2 期
Chaperone therapy of Neuronopathic Gaucher Disease with AmbroxolJPRN-jRCTs061180090Maegaki Yoshihiro25
进行中（未招募）
1 期
An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12nstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12.MedDRA version: 8.1 Level: LLT Classification code 10012547 Term: Detrusor hyperreflexiaEUCTR2006-002663-11-GBPlethora Solutions Limited18
已完成
不适用
An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12Detrusor hyper-reflexia secondary to spinal injury (mid-thoracic or cervical level)Urological and Genital DiseasesDetrusor hyper-reflexiaISRCTN81647490Plethora Solutions Ltd (UK)18
招募中
1 期
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Hematologic MalignanciesRelapsed or Refractory Hematologic MalignancyMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864EUCTR2022-000891-20-ITCuris, Inc.221
招募中
2 期
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in R/R PCNSL2024-513312-95-00Curis Inc.69